Related Experiment Video
Updated: Aug 9, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Anaesthetic implications for Pompe disease. A case description
M Ruano Santiago1, E Soto Garrucho1, Y González Marín1
1Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Universitario de Valme, Sevilla, Spain.
Pompe disease, a rare metabolic disorder, presents significant anesthesia risks, especially airway management challenges. Comprehensive preoperative assessment is crucial for managing patients with Pompe disease undergoing surgery.
Area of Science:
- Metabolic Myopathies
- Autosomal Recessive Disorders
- Anesthesiology
Background:
- Pompe disease (glycogenosis type II) is a rare, autosomal recessive metabolic myopathy causing progressive muscle weakness and multisystem issues.
- It is associated with a high risk of anesthesia complications, notably cardiac, respiratory, and difficult airway management.
- Effective perioperative risk reduction necessitates thorough preoperative evaluation.
Observation:
- This article details the anesthetic management of an adult Pompe disease patient undergoing osteosynthesis of the proximal left humerus.
- The patient's history of adult-onset Pompe disease required specialized anesthetic considerations.
Findings:
- Difficult airway management is identified as the primary anesthesia-related complication in Pompe disease patients.
- Comprehensive preoperative assessment is vital for mitigating perioperative morbidity and mortality.
Implications:
- This case highlights the critical need for meticulous preoperative assessment and planning for anesthesia in Pompe disease patients.
- Understanding the specific anesthetic risks associated with Pompe disease is essential for surgical teams to ensure patient safety.
More Related Videos
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Skeletal Muscle Relaxants: Therapeutic Uses

